Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

1,217

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2013

Conditions
Type 2 Diabetes
Interventions
DRUG

dapagliflozin

Tablet oral 2.5, 5, or 10 mg total daily dose once daily 208 weeks

DRUG

glipizide

Capsule oral 5, 10, or 20 mg total daily dose once or split/twice daily 208 weeks

DRUG

metformin hydrochloride

Tablet oral 1500, 2000, or 2500 mg total daily dose split/twice daily 218 weeks

Trial Locations (76)

Unknown

Research Site, Buenos Aires

Research Site, Caba

Research Site, Capital Federal

Research Site, Ciudad de Buenos Aires

Research Site, Corrientes

Research Site, Córdoba

Research Site, La Plata

Research Site, Rosario

Research Site, Santa Fe

Research Site, L'Aigle

Research Site, Mûrs-Erigné

Research Site, Nantes

Research Site, Paris

Research Site, Tours

Research Site, Vannes

Research Site, Bad Lauterberg im Harz

Research Site, Berlin

Research Site, Dresden

Research Site, Essen

Research Site, Frankfurt

Research Site, Hamburg

Research Site, Heilbronn

Research Site, Ludwigshafen

Research Site, Mainz

Research Site, Pirna

Research Site, Schmiedeberg

Research Site, Wangen

Research Site, Perugia

Research Site, Pisa

Research Site, Roma

Research Site, Acapulco

Research Site, Guadalajara

Research Site, México

Research Site, Veracruz

Research Site, Deurne

Research Site, Gorinchem

Research Site, Groningen

Research Site, Lichtenvoorde (gld)

Research Site, Losser

Research Site, Poortvliet

Research Site, Rotterdam

Research Site, The Hague

Research Site, Wildervank

Research Site, Zutphen

Research Site, Cape Town

Research Site, Durban

Research Site, eMkhomazi

Research Site, Johannesburg

Research Site, Parow

Research Site, Pretoria

Research Site, Witbank

Research Site, Alicante

Research Site, Alzira (Valencia)

Research Site, Barcelona

Research Site, Cornellá de Llobregat (bcn)

Research Site, Madrid

Research Site, Seville

Research Site, Gothenburg

Research Site, Järfälla

Research Site, Lund

Research Site, Malmo

Research Site, Skene

Research Site, Södertälje

Research Site, Stockholm

Research Site, Umeå

Research Site, Addlestone

Research Site, Aylesbury

Research Site, Bath

Research Site, Bolton

Research Site, Bury Saint Edmonds

Research Site, Cookstown

Research Site, Coventry

Research Site, Ecclesfield

Research Site, Edinburgh

Research Site, Mortimer Reading

Research Site, Trowbridge

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY